CSTL
Castle Biosciences Inc
NASDAQ: CSTL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$24.49
+1.03% today
Updated 2026-04-30
Market cap
$734.37M
P/E ratio
—
P/S ratio
2.13x
EPS (TTM)
$-0.83
Dividend yield
—
52W range
$15 – $44
Volume
0.4M
Castle Biosciences Inc (CSTL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $9.82M | $22.40M | $119.75M | $439.33M | $462.57M | $447.33M | $453.34M | $531.24M |
| Cash & equivalents | $1.21M | $4.48M | $98.84M | $409.85M | $329.63M | $122.95M | $98.84M | $119.71M |
| Current assets | $6.68M | $18.13M | $116.68M | $429.59M | $353.74M | $292.29M | $295.63M | $360.15M |
| Total liabilities | $24.09M | $32.47M | $34.63M | $23.64M | $50.83M | $48.18M | $62.07M | $75.40M |
| Current liabilities | $5.22M | $6.74M | $15.29M | $20.88M | $24.89M | $36.13M | $47.67M | $49.39M |
| Long-term debt | $17.60M | $24.50M | $19.29M | — | — | — | — | $9.74M |
| Shareholder equity | $-14.27M | $-10.07M | $85.11M | $415.69M | $411.74M | $399.15M | $391.27M | $455.83M |
| Retained earnings | $-51.12M | $-57.49M | $-52.21M | $-62.50M | $-93.77M | $-160.91M | $-218.37M | $-200.13M |
| Accounts receivable | $4.65M | $12.09M | $14.65M | $12.76M | $17.28M | $23.48M | $38.30M | $51.22M |
| Inventory | $304576.00 | $882233.00 | $1.24M | $2.22M | $2.02M | $3.98M | $7.94M | $8.13M |
| Goodwill | $0.00 | $0.00 | — | — | $0.00 | $10.69M | $10.69M | $10.69M |